OakChart

Surgery Partners Inc

SGRYHealthcare·Medical Care Facilities·USA·Mid·NASD·Nov 11 • 3:59 PM ET

26.66-0.07 (-0.26%)
2026-11-12 05:23 CET
Market cap
3,435.81 USD m
Revenue, TTM
3,360.10 USD m
Net income, TTM
-87.00 USD m
Free cash flow, TTM
202.80 USD m
EPS diluted, TTM
-0.68
P/E
-
Compare

Price

SGRY against its 20, 50 and 200-day averages
2050200miss
15.0020.0025.0029.4M58.8MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SGRYclose 26.6620-day 20.9350-day 16.79200-day 14.9726.66

2.1% under the 52-week high of 27.23 on 9 Nov 2026. 52-week low 11.41 on 30 Mar 2026. Last 15 sessions, 77.4% high to low

Volume 0.67× normal · the line is the 50-bar volume average

Profile

SGRY
52-week range, 96% of the way up
11.4127.23

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the Surgical Facility segment. The Surgical Facility segment includes the operation of ambulatory surgery centers, surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. The company was founded in 2004 and is headquartered in Brentwood, TN.

IndexRUT
Employees16000
IPOOct 01, 2015
Beta1.85
ATR, 14d0.81
Rel volume0.67
Short float11.48%
Insider own40.42%
Inst own83.81%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap3.49B
Enterprise Value8.04B
Income-87.00M
Sales3.36B
Book/sh12.72
Cash/sh2.71
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees16000
IPOOct 01, 2015

Ratios

P/E-
Forward P/E88.00
PEG31.43
P/S1.04
P/B2.10
P/C9.84
P/FCF17.21
EV/EBITDA13.23
EV/Sales2.39
Quick Ratio2.01
Current Ratio2.17
Debt/Eq1.99
LT Debt/Eq1.94
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.68
EPS next Y0.30
EPS next Q0.15
EPS this Y-25.89%
EPS next Y-13.02%
EPS next 5Y2.80%
EPS past 3/5Y-1.03% 28.11%
Sales past 3/5Y9.22% 12.21%
EPS Y/Y TTM50.06%
Sales Y/Y TTM2.19%
EPS Q/Q8.24%
Sales Q/Q-0.75%
EarningsNov 09 AMC
EPS/Sales Surpr.44.67% -0.69%

Ownership

Insider Own40.42%
Insider Trans0.02%
Inst Own83.81%
Inst Trans1.20%
ROA-1.16%
ROE-5.13%
ROIC-1.78%
Gross Margin16.97%
Oper. Margin12.81%
Profit Margin-2.59%
SMA2027.40%
SMA5058.79%
SMA20078.05%
Trades-

Technical

Shs Outstand130.86M
Shs Float77.98M
Short Float11.48%
Short Ratio2.29
Short Interest8.95M
52W High27.23 -2.08%
52W Low11.41 133.65%
Volatility1.89% 2.24%
ATR (14)0.81
RSI (14)90.16
Beta1.85
Rel Volume0.67
Avg Volume3.90M
Volume2,607,763

Performance

Perf Week15.11%
Perf Month83.23%
Perf Quarter75.51%
Perf Half Y86.30%
Perf YTD72.56%
Perf Year69.32%
Perf 3Y1.83%
Perf 5Y-47.11%
Perf 10Y77.14%
Recom3.00
Target Price24.33
Prev Close26.73
Price26.66
Change %-0.26%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
TodayDowngradeMMizuhoOutperform → Neutral$19 → $25-6.2%
Sep 18, 2025ResumedJJP MorganNeutral$27+1.3%
Jul 28, 2025ResumedBBofA SecuritiesBuy$28+5.0%
Dec 16, 2024InitiatedBBofA SecuritiesBuy$30+12.5%
Oct 14, 2024InitiatedUUBSBuy$38+42.5%
Oct 11, 2024InitiatedKKeyBanc Capital MarketsSector Weight
Jun 28, 2024InitiatedMMacquarieOutperform$31+16.3%
Mar 06, 2024InitiatedBBarclaysEqual Weight$35+31.3%
Nov 14, 2023UpgradeTTD CowenMarket Perform → Outperform$39 → $35+31.3%
Jun 02, 2023UpgradeBBofA SecuritiesNeutral → Buy$42 → $45+68.8%

Peers

Mkt cap
TickerCompanyMkt cap
THCTenet Healthcare Corp23.32B
HCAHCA Healthcare Inc105.71B
ARDTArdent Health Inc2.56B
CONConcentra Group Holdings Parent Inc5.50B
CYHCommunity Health Systems Inc322.95M
NUTXNutex Health Inc1.30B
UHSUniversal Health Services Inc11.34B
USPHU.S. Physical Therapy Inc1.49B
MDPediatrix Medical Group Inc2.46B
AIRSAirsculpt Technologies Inc59.55M

Insider trading

latest 14 of 26
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
DeLuca TeresaDirectorAug 18 '26Buy14.3510,000143,50066,843Aug 19 04:17 PM
Burkhalter DanielleChief Human Resources OfficerMar 13 '26Sale12.833,46944,50776,864Mar 16 04:07 PM
Brittenham MarissaChief Strategy OfficerMar 13 '26Sale12.543,65745,85994,196Mar 16 04:07 PM
Doherty David TChief Financial OfficerMar 16 '26Sale12.508,867110,838221,679Mar 16 04:07 PM
Evans Jason EricChief Executive OfficerMar 16 '26Sale12.4720,400254,388920,386Mar 16 04:07 PM
Baldock JenniferChief Admin & Dev OfficerMar 12 '26Sale13.175,79876,360326,474Mar 16 04:07 PM
David DohertyOfficerMar 16 '26Proposed Sale12.508,867110,843Mar 16 02:38 PM
Jason Eric EvansDirectorMar 16 '26Proposed Sale12.4720,400254,420Mar 16 01:59 PM
Marissa BrittenhamOfficerMar 13 '26Proposed Sale12.543,65745,859Mar 13 03:55 PM
Danielle BurkhalterOfficerMar 13 '26Proposed Sale12.833,46944,507Mar 13 03:35 PM
William T. WebbOfficerMar 12 '26Proposed Sale13.072,04526,733Mar 12 04:37 PM
Jennifer BaldockOfficerMar 12 '26Proposed Sale13.175,79876,385Mar 12 01:42 PM
Evans Jason EricChief Executive OfficerMar 06 '26Sale13.7911,462158,061662,680Mar 09 07:33 PM
Doherty David TChief Financial OfficerMar 06 '26Sale13.8414,574201,70488,803Mar 09 07:33 PM

Held by

AUM
TickerCompanyAUM
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.52B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.47B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
FNDASchwab Fundamental U.S. Small Company ETFAUM: 8.98B
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 100

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-090.1600.111-0.160815.3820.966
2026Q22026-08-100.1000.058-0.116848.9830.0312
2026Q12026-05-05-0.030-0.125-0.280810.9797.6912
2025Q42026-03-020.1200.304-0.117885866.829
2025Q32025-11-100.1300.203-0.178821.5820.037
2025Q22025-08-050.1700.177-0.020826.2818.437
2025Q12025-05-120.0400.066-0.298776777.3410
2024Q42025-03-030.4400.376-0.860864.4827.913
2024Q32024-11-120.1900.252-0.251770.4768.9913
2024Q22024-08-060.2100.200-0.123762.1735.9411
2024Q12024-05-070.1000.072-0.098717.4698.7311
2023Q42024-02-260.4400.379-0.008735.4741.4510
2023Q32023-11-070.1900.143-0.039674.1671.999
2023Q22023-08-010.2800.0810.148667.6669.4311
2023Q12023-05-010.0800.004-0.199666.2656.7410
2022Q42023-03-010.2700.203-0.230707.1688.067

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2018FY-0.891-0.492-4.9581,8061,786
2019FY-0.850-0.860-2.2891,8311,829
2020FY-1.220-1.295-3.1901,8601,860
2021FY-0.010-0.150-1.1212,2252,238
2022FY0.1600.114-0.5942,5392,520
2023FY1.0000.927-0.0952,7432,750
2024FY0.9300.851-1.3333,1143,078
2025FY0.4700.634-0.6103,3093,290
2026FY-0.348--3,196
2027FY-0.303--2,920
2028FY-0.511--3,019
2029FY-0.560--3,600

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-10716721.1669916
2026Q4S2026-11-09706714.23670916.6
2026Q4S2026-10-29706714.23670916.6
2026Q4S2026-10-26706715.18675916.6
2026Q4S2026-10-24814795.41675.7926
2026Q4S2026-10-23816795.41675.7926
2026Q4S2026-10-091016840.56676.49926
2026Q4S2026-10-051016840.59676.49926
2026Q4S2026-09-281016840.6676.49926
2026Q4S2026-09-171025864.97677926
2026Q4S2026-09-111025910.3887926
2026Q4S2026-08-101016905.87881.7920.17
2026Q4S2026-07-201000919.2905.8938.95
2026Q4S2026-07-191010919.2905.8938.95

Estimate history

EPS, annual-1.623-4.958-2.289-3.19-1.121-0.594-0.095-1.333-0.612-0.677
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.251-0.86-0.298-0.02-0.178-0.117-0.28-0.116-0.164
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1341.2191771.4561831.41860.12225.12539.32743.33114.33308.73360.1
Period201720182019202020212022202320242025TTM
Sales, quarterly770.4864.4776826.2821.5885810.9848.9815.3
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual48.68748.86949.29950.46289.333125.961126.594127.109129.321130.862
Period201720182019202020212022202320242025MRQ
Shares, quarterly127.128127.109128.193128.21129.018129.321130.797130.886130.862
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue3,360.103,308.703,114.302,743.302,539.302,225.101,860.101,831.401,771.46
Cost of Goods Sold Incl. D&A2,789.802,719.702,521.302,213.902,079.201,832.501,575.101,484.101,428.87
Gross Profit570.30589.00593.00529.40460.10392.60285.00347.30342.58
Selling, General and Administrative Excl. Other139.90118.20138.70120.90102.20104.0097.1088.6092.06
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income430.40470.80454.30408.50357.90288.60187.90258.70250.53
Interest Expense277.30279.30258.70227.70224.60196.30181.60171.40146.40
Unusual Expense84.8082.50104.4087.3031.1010.9010.9041.20153.53
Net Income Before Taxes89.30116.90147.10135.00110.3081.20-18.8054.60-69.17
Income Taxes18.6018.00134.60-0.3023.3010.50-20.109.5026.46
Consolidated Net Income70.7098.9012.50135.3087.0060.401.3045.10-95.63
Net Income From Continuing Operations-87.00-77.90-168.10-11.90-54.60-81.20-116.10-74.80-205.71
Net Income-87.00-77.90-168.10-11.90-54.60-81.20-155.60-110.50-238.13
EPS (Recurring)-0.21-0.16-0.750.39-0.36-1.02-3.03-1.69-2.72
EPS (Basic, Before Extraordinaries)-0.68-0.61-1.33-0.09-0.59-1.12-3.19-2.29-4.96
EPS (Diluted)-0.68-0.61-1.33-0.09-0.59-1.12-3.19-2.29-4.96
EBITDA607.70647.10607.80526.60507.50426.50322.10375.20317.97
Non-Operating Income (Expense)21.007.9055.9041.508.10-0.20-14.208.50-19.76
Other After Tax Adjustments0.000.000.000.000.00-10.300.000.000.00
Stock Option Compensation Expense240.8311.6926.4614.6222.509.009.647.457.38
Price To Sales Ratio0.530.590.861.461.011.740.760.410.27
Gross Margin16.9717.8019.0419.3018.1217.6415.3218.9619.34
Operating Margin12.8114.2314.5914.8914.0912.9710.1014.1314.14
Net Margin-2.59-2.35-5.40-0.43-2.15-3.65-8.37-6.03-13.44
Shares Outstanding130.86129.32127.11126.59125.9689.3350.4649.3048.87
Market Capitalization3,435.813,435.812,691.004,302.433,257.954,723.401,464.85782.73478.65

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue815.30848.90810.90885.00821.50826.20776.00864.40
Cost of Goods Sold Incl. D&A669.90698.00689.20732.70665.70670.90650.40664.70
Gross Profit145.40150.90121.70152.30155.80155.30125.60199.70
Selling, General and Administrative Excl. Other40.6036.3039.3023.7022.4036.1036.0036.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income104.80114.6082.40128.60133.40119.2089.60163.70
Interest Expense69.4071.2070.5066.2073.3066.6073.2065.60
Unusual Expense27.1021.1018.1018.5019.0018.1015.9034.00
Net Income Before Taxes17.7032.30-3.3042.6030.8043.80-0.3074.20
Income Taxes3.602.60-1.2013.605.50-1.100.00120.80
Consolidated Net Income14.1029.70-2.1029.0025.3044.90-0.30-46.60
Net Income From Continuing Operations-21.10-15.00-35.90-15.00-22.70-2.50-37.70-108.50
Net Income-21.10-15.00-35.90-15.00-22.70-2.50-37.70-108.50
EPS (Recurring)-0.02-0.00-0.18-0.02-0.070.08-0.21-0.67
EPS (Basic, Before Extraordinaries)-0.16-0.12-0.28-0.12-0.18-0.02-0.30-0.86
EPS (Diluted)-0.16-0.12-0.28-0.12-0.18-0.02-0.30-0.86
EBITDA144.40153.90120.90188.50172.90159.50125.90197.60
Non-Operating Income (Expense)9.4010.002.90-1.30-10.309.30-0.8010.10
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense4.423.00235.60-2.204.905.377.604.90
Price To Sales Ratio0.530.640.460.600.840.870.950.86
Gross Margin17.8317.7815.0117.2118.9718.8016.1923.10
Operating Margin12.8513.5010.1614.5316.2414.4311.5518.94
Net Margin-2.59-1.77-4.43-1.69-2.76-0.30-4.86-12.55
Shares Outstanding130.86130.89130.80129.32129.02128.21128.19127.11
Market Capitalization3,435.812,197.241,542.691,998.332,774.442,849.003,030.812,691.00

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments239.90269.50195.90282.90389.90317.9092.70184.31178.72
Short Term Receivables602.20579.10513.60456.30430.20382.20335.50316.14298.41
Inventories96.6088.4075.2071.4061.1056.4046.3043.3644.95
Other Current Assets212.00182.40110.30110.4064.9045.0051.0044.5141.14
Total Current Assets1,150.701,119.40895.00921.00946.10801.50525.50588.32563.23
Net Property, Plant & Equipment1,442.601,384.001,224.001,155.70953.80854.70821.00426.29398.54
Total Investments and Advances234.00215.40241.50303.70112.3090.6093.5078.7894.20
Long-Term Note Receivable--17.20-----12.28
Intangible Assets5,235.605,113.704,380.804,179.403,955.503,514.903,449.703,437.143,405.75
Deferred Tax Assets122.30118.90231.90257.50235.40248.70221.60161.47160.70
Other Assets56.8057.5028.7030.8035.5026.7030.5036.5516.47
Total Assets8,242.008,008.907,019.106,848.106,238.605,537.105,141.804,728.544,651.15
Short Term Debt Incl. Current Port. of LT Debt142.00142.40110.9099.30100.50103.6093.3062.5565.03
Accounts Payable208.70208.70177.00151.60124.90100.2096.7083.2984.71
Income Tax Payable--------4.91
Other Current Liabilities264.80273.30235.10242.50311.40353.00208.10203.46148.36
Total Current Liabilities615.50624.40523.00493.40536.80556.80398.10349.30303.00
Long Term Debt3,882.803,561.002,950.702,830.403,194.003,093.302,807.802,420.712,264.07
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities175.70158.10142.40166.00121.00123.90122.9052.2828.38
Other Liabilities41.2030.2041.1075.4087.00139.70113.60121.3888.96
Total Liabilities4,715.204,373.703,657.203,565.203,938.803,913.703,442.402,943.662,684.42
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.00434.50395.00359.35330.81
Common Equity1,712.901,789.701,987.201,998.201,089.00115.60296.80404.64654.73
Total Shareholders Equity1,712.901,789.701,987.201,998.201,089.00550.10691.80763.99985.54
Accumulated Minority Interest1,813.901,845.501,374.701,284.701,210.801,073.301,007.601,020.90981.20
Total Equity3,526.803,635.203,361.903,282.902,299.801,623.401,699.401,784.881,966.73
Total Liabilities & Stockholders Equity8,242.008,008.907,019.106,848.106,238.605,537.105,141.804,728.544,651.15
Book Value Per Share13.2514.0815.7015.8612.192.296.028.2813.45
Tangible Book Value Per Share-27.24-26.15-18.91-17.32-32.09-67.36-63.95-62.05-56.50
Full-Time Employees16,00015,00013,50012,20010,90010,8006,90011,00010,600
Price to Book Ratio2.101.422.022.144.3812.662.601.180.85
Return on Assets-0.96-2.24-0.17-0.83-1.38-2.17-1.52-4.39-1.97
Return on Equity-4.45-8.90-0.60-3.54-9.91-18.70-10.28-23.52-13.78
Return on Invested Capital-1.39-3.14-0.24-1.13-1.90-3.19-2.14-6.46-2.11
Quick Ratio1.711.651.571.721.651.341.201.561.71
Current Ratio1.871.791.711.871.761.441.321.681.86

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income70.7098.9012.50135.3087.0070.701.3045.10-95.63
Depreciation177.30176.00152.60118.10149.60137.90134.20116.5067.44
Other Funds (Non Cash)86.7093.10122.40105.6061.0050.9057.4028.20114.35
Funds from Operations347.00384.70419.00357.30319.50268.40171.00198.30111.44
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-69.10-110.40-118.90-63.50-160.70-181.3075.90-68.8033.16
Cash from Operating Activities277.90274.30300.10293.80158.8087.10246.90129.50144.60
Capital Expenditures-75.10-78.70-90.40-88.80-80.60-57.60-42.90-73.60-39.80
Net Assets From Acquisitions-119.70-162.10-378.80-80.00-146.40-285.80-104.60-13.80-106.77
Sale of Fixed Assets and Businesses501.9046.502.6025.8012.906.0058.5017.6019.17
Purchase or Sale of Investments2.50-11.802.90-48.90-82.305.400.00-15.200.00
Purchase of Investments0.10-13.30-1.70-50.30-95.100.000.00-15.200.00
Sale Or Maturity of Investments2.401.504.601.4012.805.400.000.000.00
Other Uses-9.00-40.50-24.80-33.70-11.500.000.00-0.20-1.46
Other Sources8.100.000.000.000.000.300.600.000.00
Cash from Investing Activities308.70-246.60-488.50-225.60-307.90-331.70-88.40-85.20-128.86
Cash Dividends Paid0.000.000.000.000.00-5.100.000.00-7.81
Change in Capital Stock0.000.000.000.00857.70554.200.000.00-1.98
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00-1.98
Sale of Common Pref Stock0.000.000.000.00857.70554.200.000.000.00
Proceedsfrom Stock Options0.000.000.000.00857.70554.200.000.000.00
Issuance or Reduction of Debt, Net-223.70158.70435.50-4.80-655.50-55.50204.60-10.60115.91
Change in Long Term Debt-223.70158.70435.50-4.80-655.50-55.50204.60-10.60115.91
Issuance of Long Term Debt1,214.301,198.501,714.80802.30217.80287.70420.90498.00279.75
Reduction of Long Term Debt-1,438.00-1,039.80-1,279.30-807.10-873.30-343.20-216.30-508.60-163.84
Net Financing Active Other Cash Flow-211.80-216.00-173.50-150.40-160.10-177.30-137.90-125.30-112.46
Other Financing Activities Uses-217.60-226.00-183.10-158.60-160.10-177.30-137.90-125.30-112.46
Cash from Financing Activities-435.50-57.30262.00-155.2042.10316.3066.70-135.90-6.34
Net Change in Cash151.10-29.6073.60-87.00-107.0071.70225.20-91.609.39
Free Cash Flow202.80195.60209.70205.0078.2029.50204.0055.90104.80
Preferred Dividends (Cash Flow)-0.000.000.000.00-5.100.000.00-7.81
Price to Free Cash Flow8.8110.0512.7319.6032.76158.546.9413.524.85
Deferred Taxes & Investment Tax Credit-16.70131.50-1.7021.908.90-21.908.5025.27

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments354.50216.70182.30239.90203.40250.10
Short Term Receivables468.10616.60603.40602.20579.30563.10
Inventories77.5098.80100.5096.6092.3087.30
Other Current Assets179.90193.90196.30212.00227.20204.80
Total Current Assets1,080.001,126.001,082.501,150.701,102.201,105.30
Net Property, Plant & Equipment1,069.901,401.201,416.401,442.601,439.701,451.20
Total Investments and Advances225.40226.90225.40234.00229.40220.20
Intangible Assets4,643.505,242.105,245.005,235.605,134.605,140.00
Deferred Tax Assets---122.30--
Other Assets31.0053.5072.8056.8040.7038.10
Total Assets7,049.808,049.708,042.108,242.007,946.607,954.80
Short Term Debt Incl. Current Port. of LT Debt89.60143.50142.60142.00144.30149.60
Accounts Payable140.70175.20168.60208.70174.60174.90
Other Current Liabilities268.30259.80270.50264.80267.10248.80
Total Current Liabilities498.60578.50581.70615.50586.00573.30
Long Term Debt3,223.103,914.603,885.403,882.803,726.903,728.90
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities52.4054.4052.10175.7042.6037.40
Other Liabilities19.0033.8041.6041.2038.1036.30
Total Liabilities3,793.104,581.304,560.804,715.204,393.604,375.90
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,664.601,670.701,688.001,712.901,729.501,748.30
Total Shareholders Equity1,664.601,670.701,688.001,712.901,729.501,748.30
Accumulated Minority Interest1,592.101,797.701,793.301,813.901,823.501,830.60
Total Equity3,256.703,468.403,481.303,526.803,553.003,578.90
Total Liabilities & Stockholders Equity7,049.808,049.708,042.108,242.007,946.607,954.80
Book Value Per Share12.7212.7612.9113.2513.4113.64
Tangible Book Value Per Share-22.76-27.29-27.19-27.24-26.39-26.45
Full-Time Employees---16,000--
Price to Book Ratio2.101.300.901.151.591.64
Return on Assets-1.16-1.11-0.95-0.96-2.21-2.34
Return on Equity-5.13-5.18-4.44-4.45-9.45-9.75
Return on Invested Capital-0.43-0.27-0.64-0.27-0.42-0.05
Quick Ratio2.011.781.691.711.721.78
Current Ratio2.171.951.861.871.881.93

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income14.1029.70-2.1029.0025.3044.90
Depreciation39.6039.3038.5059.9039.5040.30
Other Funds (Non Cash)24.7016.3026.2019.5032.1014.30
Funds from Operations76.4087.5061.30121.80102.0098.00
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital27.10-28.20-49.60-18.40-18.40-16.70
Cash from Operating Activities103.5059.3011.70103.4083.6081.30
Capital Expenditures-24.50-21.80-16.00-12.80-19.80-23.40
Net Assets From Acquisitions-6.100.10-4.20-109.50-4.60-4.00
Sale of Fixed Assets and Businesses498.000.300.003.600.0038.10
Purchase or Sale of Investments0.000.000.901.60-9.600.00
Purchase of Investments0.000.000.000.10-9.600.00
Sale Or Maturity of Investments0.000.000.901.500.000.00
Other Uses0.000.000.00-9.00-12.20-8.60
Other Sources0.601.605.900.000.000.00
Cash from Investing Activities468.00-19.80-13.40-126.10-46.202.10
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-373.7038.201.20110.60-34.70-11.50
Change in Long Term Debt-373.7038.201.20110.60-34.70-11.50
Issuance of Long Term Debt174.70154.60195.00690.00126.30168.60
Reduction of Long Term Debt-548.40-116.40-193.80-579.40-161.00-180.10
Net Financing Active Other Cash Flow-60.00-43.30-57.10-51.40-49.40-51.10
Other Financing Activities Uses-56.90-45.50-58.00-57.20-50.50-52.50
Cash from Financing Activities-433.70-5.10-55.9059.20-84.10-62.60
Net Change in Cash137.8034.40-57.6036.50-46.7020.80
Free Cash Flow79.0037.50-4.3090.6063.8057.90
Price to Free Cash Flow8.8111.547.3610.1114.1816.10

Revenue breakdown

Government2024: 1.26B 2025: 1.38B
Other Patient Service Revenue Sources2024: 81.10M 2025: 71.20M
Other Services2024: 59.90M 2025: 82.40M
Private Insurance2024: 1.63B 2025: 1.69B
Self-Pay2024: 82.30M 2025: 87.60M
United States2024: 3.11B 2025: 3.31B
Total Services-General Medical & Surgical Hospitals, NEC revenue2024: 3.11B 2025: 3.31B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3011.66%9.0M76.8M3.34M
2026-10-1518.37%14.3M78.0M2.14M
2026-09-3018.40%14.3M78.0M2.14M
2026-09-1517.04%13.3M78.0M1.92M
2026-08-3116.61%13.0M78.0M1.79M
2026-08-1416.22%12.7M78.0M1.51M
2026-07-3117.37%13.5M77.9M1.54M
2026-07-1518.99%14.8M77.9M1.44M
2026-06-3019.40%15.1M78.0M1.40M
2026-06-1518.31%14.3M78.0M1.36M
2026-05-2917.58%13.7M78.1M1.57M
2026-05-1518.56%14.5M78.1M1.61M
2026-04-3020.20%15.8M78.3M1.56M
2026-04-1520.60%15.8M76.9M1.61M
2026-03-3118.08%14.0M77.4M1.66M
2026-03-1317.34%13.4M77.4M1.73M
2026-02-2717.84%13.8M77.4M1.61M
2026-02-1321.18%16.4M77.4M1.70M
2026-01-3022.89%17.7M77.5M1.90M
2026-01-1520.05%15.5M77.5M1.84M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.5022.1026.200.000.0000.000.000.996-0.0190.000
call5.0019.6023.700.0013.1730.000.000.994-0.0200.001
call7.5017.1021.200.009.7410.000.000.992-0.0200.001
call10.0015.0018.705.507.6761.000.000.990-0.0200.001
call12.5013.9016.2014.406.2041400.000.987-0.0200.001
call15.0011.4013.7011.905.0462110.000.984-0.0190.002
call17.508.9011.209.404.08368.000.000.979-0.0190.002
call20.005.008.702.803.2424.000.000.971-0.0180.003
call22.502.656.204.352.47612.000.000.957-0.0170.004
call25.001.452.501.700.3932157.000.906-0.0150.007
call27.500.050.200.150.3011,23816.000.397-0.0580.016
call30.000.000.100.030.47435.000.000.061-0.0140.005
call32.500.002.150.000.8180.000.000.069-0.0250.006
call35.000.002.150.001.0420.000.000.057-0.0280.005
call37.500.002.150.001.2410.000.000.049-0.0290.004
call40.000.002.150.001.4210.000.000.044-0.0310.004
put2.500.000.050.006.8370.000.00-0.004-0.0170.000
put5.000.000.050.004.7930.000.00-0.006-0.0170.001
put7.500.000.050.003.6600.000.00-0.008-0.0170.001
put10.000.000.050.052.8732.000.00-0.010-0.0170.001
put12.500.000.050.022.33862.000.00-0.013-0.0180.001
put15.000.000.050.051.77328.000.00-0.016-0.0160.002
put17.500.000.050.051.3501.000.00-0.021-0.0150.002
put20.000.000.050.050.97621.000.00-0.029-0.0140.003
put22.500.000.050.010.6357151.00-0.044-0.0140.004
put25.000.000.050.050.3059622.00-0.097-0.0130.007
put27.500.003.204.401.23330.000.00-0.603-0.0550.016
put30.001.405.500.002.0630.000.00-0.939-0.0100.005
put32.503.908.000.002.4830.000.00-0.957-0.0120.004
put35.006.4010.500.002.8390.000.00-0.965-0.0130.003
put37.508.9013.000.003.1500.000.00-0.970-0.0140.003
put40.0011.4015.500.003.4260.000.00-0.974-0.0140.003

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-098-KCurrent report2026-11-09SEC
2026-11-09DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-11-09DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-11-09DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-11-098-KCurrent report2026-11-08SEC
2026-11-06SCHEDULE 13G/ASEC
2026-10-28DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-10-27DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-10-26SCHEDULE 13D/ASEC
2026-10-26DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-10-26DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-10-268-KCurrent report2026-10-23SEC
2026-10-13SCHEDULE 13GSEC
2026-09-178-KCurrent report2026-09-14SEC
2026-08-204/A2026-08-18SEC
2026-08-194Statement of changes in beneficial ownership of securities2026-08-18SEC
2026-08-14SCHEDULE 13GSEC
2026-08-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-108-KCurrent report2026-08-10SEC
2026-07-248-KCurrent report2026-07-21SEC
2026-07-144Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-094Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-094Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-094Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-094Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-094Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-094Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-094Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-058-KCurrent report2026-06-05SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-08143.50K100
2026-070000
2026-060000
2026-050000
2026-040000
2026-03001.28M12
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BAIN CAPITAL INVESTORS LLC38.19%
Jupiter Topco LLC10.61%
Pentwater Capital Management LP8.89%
UBS Group AG6.99%
BlackRock, Inc.4.77%
KING STREET CAPITAL MANAGEMENT, L.P.4.63%
T. Rowe Price Investment Management, Inc.4.52%
DIMENSIONAL FUND ADVISORS LP4.52%
Clearbridge Investments, LLC2.92%
VANGUARD PORTFOLIO MANAGEMENT LLC2.86%

Funds

Fund% owned
Janus Henderson Contrarian Fund10.14%
VANGUARD TOTAL STOCK MARKET INDEX FUND1.90%
T. Rowe Price Small-Cap Stock Fund, Inc.1.60%
iShares Russell 2000 ETF1.59%
VANGUARD SMALL-CAP INDEX FUND1.38%
ClearBridge Select Fund1.22%
U.S. SMALL CAP VALUE PORTFOLIO1.07%
ClearBridge Small Cap Growth Fund0.95%
VANGUARD SMALL-CAP VALUE INDEX FUND0.87%
T. Rowe Price Institutional Small-Cap Stock Fund0.86%

OakChart. SGRY. Cached 15 minutes.